Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.37 |
| ▸ | HRH2 known ✓ | P25021 | 1/20 | 0.37 |
| ▸ | HRH3 known ✓ | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.37 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10458788 | 1.00 | L3MBTL1 (0.61) | L3MBTL1TDP1HRH1HRH4HRH2 | |
| Hydrochloric Acid SCHEMBL10458809 | 1.00 | L3MBTL1 (0.61) | L3MBTL1TDP1HRH1HRH4HRH2 | |
| SCHEMBL9628501 | 0.98 | L3MBTL1 (0.58) | L3MBTL1TDP1HRH1HRH4HRH2 | |
| Bromide SCHEMBL11311978 | 0.97 | L3MBTL1 (0.57) | L3MBTL1TDP1HRH1HRH4HRH2 | |
| Sulfuric Acid SCHEMBL10459948 | 0.89 | L3MBTL1 (0.50) | L3MBTL1TDP1HRH1HRH4HRH2 | |
| SCHEMBL11357850 | 0.88 | L3MBTL1 (0.47) | L3MBTL1TDP1HRH1HRH4HRH2 | |
| Bromide SCHEMBL11322608 | 0.87 | L3MBTL1 (0.46) | L3MBTL1TDP1HRH1HRH4HRH2 | |
| SCHEMBL11720334 | 0.83 | L3MBTL1 (0.49) | L3MBTL1TDP1HRH1HRH4HRH2 | |
| SCHEMBL11221673 | 0.81 | L3MBTL1 (0.39) | L3MBTL1SLC47A1SMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL11035051 | 0.81 | L3MBTL1 (0.39) | L3MBTL1TDP1HRH2SLC47A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115960048-B | Cimetidine Process for the preparation of guanidine | 常州安迪沃克医药科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-115960048-A | Preparation method of cimetidine | 常州安迪沃克医药科技有限公司 | 2023-04-14 | — | — | CN | claimed |
| EP-0004535-B1 | PROCESS FOR PREPARING 4-METHYL-5-((2-AMINOETHYL)-THIOMETHYL)-IMIDAZOLE-DIHYDRO CHLORIDE | BASF Aktiengesellschaft (DE) | 1981-04-29 | — | — | EP | claimed |
| EP-0006102-B1 | 1-HYDROXYMETHYLIMIDAZOLES, THEIR PREPARATION AND USE AS CHEMICAL INTERMEDIATES | BASF Aktiengesellschaft (DE) | 1981-02-11 | — | — | EP | claimed |
| US-4242517-A | 4-METHYL-1 -HYDROXYMETHYLIMIDAZOLE AND CYSTEAMINE IN BOILING AQUEOUS HYDROCHLORIC ACID | BASF AKTIENGESELLSCHAFT (DE) | 1980-12-30 | — | — | US | claimed |
| US-4189592-A | Preparation of 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole dihydrochloride | BASF AKTIENGESELLSCHAFT (DE) | 1980-02-19 | — | — | US | claimed |
| EP-0006102-A1 | 1-Hydroxymethylimidazoles, their preparation and use as chemical intermediates | BASF Aktiengesellschaft (DE) | 1980-01-09 | — | — | EP | claimed |
| EP-0004535-A2 | Process for preparing 4-methyl-5-((2-aminoethyl)-thiomethyl)-imidazole-dihydro chloride | BASF Aktiengesellschaft (DE) | 1979-10-17 | — | — | EP | claimed |
| JP-1085967-A | — | — | None | — | — | JP | disclosed |
| CN-115960048-B | Cimetidine Process for the preparation of guanidine | 常州安迪沃克医药科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-115960048-B | Cimetidine Process for the preparation of guanidine | 常州安迪沃克医药科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-115960048-A | Preparation method of cimetidine | 常州安迪沃克医药科技有限公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-115960048-A | Preparation method of cimetidine | 常州安迪沃克医药科技有限公司 | 2023-04-14 | — | — | CN | disclosed |
| US-5750714-A | Process for the manufacture of related intermediates including cistofur | BRANTFORD CHEMICALS INC. (CA) | 1998-05-12 | — | — | US | disclosed |
| US-4024271-A | INHIBITORS OF HISTAMINE ACTIVITY | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-17 | — | — | US | disclosed |
| US-4022797-A | PHARMACEUTICALS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-10 | — | — | US | disclosed |
| US-4018931-A | INHIBITION OF H-2 HISTAMINE RECEPTORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-04-19 | — | — | US | disclosed |
| US-4000302-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-12-28 | — | — | US | disclosed |
| US-3950353-A | HISTAMINE INHIBITORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-04-13 | — | — | US | disclosed |
| US-3950333-A | HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-04-13 | — | — | US | disclosed |